Which has grown faster, ANGO or OABI?

Over the past five years, ANGO grew revenue faster — ANGO at a 1.93% CAGR versus OABI at -4.31%.

How have ANGO and OABI total returns compared?

Over the past 5 years, ANGO delivered -10.80% and OABI delivered -13.17% annualized total return. Past performance doesn't predict future results.

AngioDynamics, Inc. (ANGO) vs OmniAb, Inc. (OABI)

A side-by-side comparison of AngioDynamics, Inc. and OmniAb, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANGO

AngioDynamics, Inc.

$596M

$14.43HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT

OABI

OmniAb, Inc.

$639M

$4.41HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

Total return — ANGO vs OABI

growth of $100 · dividends reinvested · last 5y

ANGO -35.8% (-8.5%/yr)OABI -49.6% (-12.8%/yr)ANGO compounded faster over this window

ANGO OABI

ANGO vs OABI: by the numbers

•OABI is the larger company ($639M vs $596M market cap).
•Both run net losses; ANGO's is the smaller (-11.48% vs -115.18% net margin).
•ANGO grew revenue faster over the past five years (1.93% vs -4.31% CAGR).

Metrics side by side

Valuation

Metric	ANGO	OABI
P/S ratio	1.86	16.64
P/B ratio	3.49	2.46
FCF yield	0.09%	N/A

Profitability

Metric	ANGO	OABI
Gross margin	54.62%	-18.17%
Operating margin	-12.47%	-383.15%
Net margin	-11.48%	-115.18%
ROE	-21.51%	-17.01%
ROIC	-20.75%	-17.48%

Growth (annualized)

Metric	ANGO	OABI
Revenue CAGR (5Y)	1.93%	-4.31%
FCF CAGR (5Y)	-51.49%	N/A
Total return CAGR (5Y)	-10.80%	-13.17%

Frequently asked

Which has grown faster, ANGO or OABI?: Over the past five years, ANGO grew revenue faster — ANGO at a 1.93% CAGR versus OABI at -4.31%.
How have ANGO and OABI total returns compared?: Over the past 5 years, ANGO delivered -10.80% and OABI delivered -13.17% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANGO analysis Full OABI analysis Interactive comparison tool

Dig into the metrics

AngioDynamics ROE OmniAb ROE AngioDynamics operating margin OmniAb operating margin AngioDynamics revenue growth OmniAb revenue growth AngioDynamics free cash flow OmniAb free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.